重大疾病防治专栏

支气管镜肺泡灌洗辅助治疗难治性肺炎支原体肺炎患儿的疗效

  • 陈丽娟 ,
  • 袁霞 ,
  • 刘情情
展开
  • 中国人民解放军联勤保障部队第九九〇医院儿科,河南驻马店 463000

收稿日期: 2022-10-27

  网络出版日期: 2023-09-22

Effect of the adjuvant therapy with bronchoalveolar lavage in treatment of children with refractory mycoplasma pneumonia

  • CHEN Lijuan ,
  • YUAN Xia ,
  • LIU Qingqing
Expand
  • Department of Pediatrics, No.990 Hospital, Joint Logistics Support Force of the Chinese People's Liberation Army, Zhumadian 463000, China

Received date: 2022-10-27

  Online published: 2023-09-22

摘要

目的:探讨电子支气管镜肺泡灌洗辅助治疗对难治性肺炎支原体肺炎(RMPP)患儿疗效、肺表面活性蛋白、乳酸脱氢酶(LDH)、穿透素3(PTX3)水平及血气指标的影响。方法:回顾性收集本院2016年10月至2022年6月收治的RMPP患儿97例,根据采取的治疗方案不同,分为药物治疗组(48例)和肺泡灌洗组(49例)。药物治疗组采用常规的大环内酯类为主的抗感染治疗及对症治疗,肺泡灌洗组在药物治疗组的基础上,给予支气管镜支气管肺泡灌洗治疗。对比两组患儿的疗效、治疗前后肺表面活性蛋白A(SP-A)、肺表面活性蛋白D(SP-D)、LDH、PTX3水平及血气分析相关指标。结果:肺泡灌洗组的总有效率为89.80 %,明显高于药物治疗组(70.83 %)(P<0.05)。治疗前,两组患儿SP-A、SP-D、LDH、PTX3水平及血气分析指标比较,无显著差异(P>0.05)。治疗后,肺泡灌洗组患儿SP-A、SP-D、LDH、PTX3水平明显低于药物治疗组,血气指标明显优于药物治疗组(P<0.05)。肺泡灌洗组患儿不良反应发生率(10.00 %)明显低于药物治疗组(26.00 %)(P<0.05)。结论:采用支气管镜支气管肺泡灌洗辅助药物治疗RMPP具有较好的疗效,可显著改善患儿肺的血气指标,降低肺表面活性蛋白(SP-A、SP-D)、LDH、PTX3水平,且安全性高。

本文引用格式

陈丽娟 , 袁霞 , 刘情情 . 支气管镜肺泡灌洗辅助治疗难治性肺炎支原体肺炎患儿的疗效[J]. 包头医学院学报, 2023 , 39(9) : 70 -73 . DOI: 10.16833/j.cnki.jbmc.2023.09.014

Abstract

Objective: To analyze the effect of the adjuvant therapy with bronchoalveolar lavage, pulmonary surfactant protein,lactate dehydrogenase (LDH), penetrating hormone 3 (PTX3) level, and arterial blood gas indexes in children with refractory mycoplasma pneumonia (RMPP). Methods: Clinical data of 97 children with RMPP in our hospital from October 2016 to June 2022 were collected retrospectively, and divided into the drug treatment group (48 cases) and bronchoalveolar lavage group (49 cases) according to the different treatment methods. The children in the drug treatment group were treated with macrolide for anti-infection and symptomatic treatment. The children in the bronchoalveolar lavage group were treated with bronchoscopic bronchoalveolar lavage on the basis of the drug treatment group. The curative effect, the levels of pulmonary surfactant protein A (SP-A), pulmonary surfactant protein D (SP-D), LDH and PTX3 and arterial blood gas indexes before and after treatment of the two groups were compared. Results: The total effective rate in the bronchoalveolar lavage group was 89.80 %, which was obviously higher than that in the drug treatment group (70.83 %) (P<0.05). Before treatment, the levels of SP-A, SP-D, LDH, PTX3 and arterial blood gas indexes had no significant difference between the two groups (P>0.05). After treatment, the levels of SP-A, SP-D, LDH and PTX3 in the bronchoalveolar lavage group were obviously lower than those in the drug treatment group, and the arterial blood gas indexes were obviously better than those in the drug treatment group (P<0.05). The incidence of adverse reactions in the bronchoalveolar lavage group (10.00 %) was obviously lower than the drug treatment group (26.00 %) (P<0.05). Conclusion: The adjuvant therapy with bronchoalveolar lavage in the treatment children with RMPP has a good treatment effect, which could significantly improve the arterial blood gas indexes and lower the levels of pulmonary surfactant protein (SP-A, SP-D), LDH and PTX3 with high safety.

参考文献

[1] 张天骄,刘盈盈,裴亮. 儿童肺炎支原体肺炎并发坏死性肺炎的临床预测因素[J].中国医科大学学报,2022,51(1): 79-82.
[2] 何雯,张琪,刘文君,等. 大环内酯类抗生素联合纤支镜肺泡灌洗治疗难治性肺炎支原体感染患儿的临床疗效[J].药学服务与研究,2021,21(4): 257-261,283.
[3] 中华医学会儿科学分会呼吸学组,中华实用儿科临床杂志·编辑委员会. 儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,17(30): 1304-1308.
[4] 岑敏,秦人豪,王海风. 肺炎支原体肺炎儿童血清miR-16的表达水平及其对肺炎支原体免疫的作用[J].东南大学学报(医学版),2022,41(3): 345-351.
[5] Tsai TA,Tsai CK,Kuo KC,et al. Rational stepwise approach for mycoplasma pneumoniae pneumonia in children[J].J Microbiol Immunol Infect,2021,54(4): 557-565.
[6] 高枫. 纤支镜支气管灌洗对儿童难治性肺炎支原体肺炎临床症状、炎症因子水平的影响[J].系统医学,2022,7(9): 10-14.
[7] 梁丹丹,纵书芳. 小儿难治性肺炎支原体肺炎肺泡灌洗液SF、SP-A、SP-D变化及其对治疗效果预测价值[J].临床误诊误治,2021,34(11): 92-96.
[8] 郑雪香,林继雷,代继宏. 基于决策曲线和剂量反应分析评估乳酸脱氢酶对儿童难治性肺炎支原体肺炎的预测价值[J].中国当代儿科杂志,2020,22(2): 112-117.
[9] 曹芳,方识进,华山,等. 电子纤维支气管镜保留灌注乙酰半胱氨酸及布地奈德治疗儿童难治性支原体肺炎的临床效果观察[J].中国医药,2020,15(3): 369-373.
文章导航

/